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ABSTRACT : 
A STUDY ON OUTCOME OF CHILDREN WITH DENGUE  INFECTION 
AND ITS CLINICAL CORELATION WITH HEPATIC DYSFUNCTION  IN 
GMKMCH 
 Dengue virus infection is a Major Public Health problem with upsurge in 
complicated and  atypical manifestations in the recent years. Hepatic involvement in 
Dengue is known with protean of manifestations ranging from hepatomegaly elevated 
liver enzymes to fulminant hepatic failure. 
 
OBJECTIVE : 
 To study hepatic dysfunction in childhood dengue infection. 
To  study clinical co-relation lilke severity, Clilnical Features, other lab parameters, 
morbidity and mortality. 
 
STUDY DESIGN : 
Prospective Cohort Study 
 
SETTINGS :  
 GMKMCH , SALEM 
 
SAMPLE SIZE : 
100  Patients hospitalized with Dengue infection (Sero Positive for Dengue) 
 
 
 
 
 
METHODOLOGY : 
  Dengue Sero positive patients are selected and examined for Hepatomegaly 
and Jaundice and subjected to complete blod count, Liver function tests, ultrasound 
abdomen, PT, APTT, HBsAg, HCV, Widal and analysed. 
SIGNIFICANCE OF THE STUDY : 
· The degree of Hepatic Dysfuction in dengue could be identified early and the 
severity of the disease could be assessed. 
· Early interventions could prevent life threatening complications like massive 
Haemorrhage. 
· The Role of  Hepato-protective drugs in dengue could be tried for early 
recovery and there by decreasing morbidity and mortality in future studies. 
 
ETHICAL CONSIDERATIONS : 
Informed written consent is obtained from parents of patients. 
 
CONCLUSION 
   
 In developing country like India, incidence of Dengue outbreaks ins increasing 
Hepatic Involvement of varying degrees have been reported. As hepatic dysfunction 
in Dengue is transient and reversible, early identification  of the same should help to 
reduce life threatening complications. This can help to reduce the Morbidity and 
Morality due to Dengue infection. The Role of Hepato Protective Drugs in reducing 
morbidity and mortality should be analysed by further studies. 
 
